<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03463668</url>
  </required_header>
  <id_info>
    <org_study_id>DYSPHAGIE-IPC 2017-036</org_study_id>
    <nct_id>NCT03463668</nct_id>
  </id_info>
  <brief_title>Evaluation of the Efficacy of Duodenal Prostheses Not Covered Over 6 Years</brief_title>
  <acronym>DYSPHAGIE</acronym>
  <official_title>Evaluation of the Efficacy of Duodenal Prostheses Not Covered Over 6 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Paoli-Calmettes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Paoli-Calmettes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the efficacy of duodenal prostheses for duodenal stenosis established for
      endoscopic pyloric or duodenal stenosis on dysphagia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Duodenal prostheses have become, since the 2000s, the first-line treatment of unresectable
      duodenal tumoral stenosis. The technical success is greater than 90%, however the endoscopic
      revisions that are duodenal or biliary are frequent. The IPC as a center of interventional
      endoscopy is very often in charge of these stenoses. We wanted to evaluate the efficiency and
      the duration of this effectiveness in current situation. Is there still room for
      gastrojejunal gastrojejunal surgery or for the development of endoscopic gastrojejunal
      anastomoses?
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 22, 2017</start_date>
  <completion_date type="Anticipated">December 2029</completion_date>
  <primary_completion_date type="Anticipated">December 2029</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dysphagia assessment</measure>
    <time_frame>7 years</time_frame>
    <description>GOOSS = Gastric Outlet Obstruction Scoring System</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of complications</measure>
    <time_frame>7 years</time_frame>
    <description>Rate of complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative survival</measure>
    <time_frame>7 years</time_frame>
    <description>defined as the time between the date of duodenal prosthesis insertion and the date of death or the latest news</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Permeability duration of the duodenal stent</measure>
    <time_frame>7 years</time_frame>
    <description>defined as the time between the date of the laying of the duodenal stent and date of patient's death or RED or surgery (exceptional case) or latest news</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of duodenal endoscopic resection at 1 and 3 months postoperatively</measure>
    <time_frame>at 1 and 3 months postoperatively</time_frame>
    <description>Rate of duodenal endoscopic resection at 1 and 3 months postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of biliary endoscopic resection at 1 and 3 months postoperatively</measure>
    <time_frame>at 1 and 3 months postoperatively</time_frame>
    <description>Rate of biliary endoscopic resection at 1 and 3 months postoperatively</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Digestive or Non-digestive Neoplasia Leading to Symptomatic Duodenal Stenosis</condition>
  <arm_group>
    <arm_group_label>symptomatic non-covered duodenal prosthesis</arm_group_label>
    <description>Any symptomatic duodenal stenosis with symptomatic duodenal duodenal prosthesis between 2010 and 2017.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>uncovered metal duodenal prosthesis</intervention_name>
    <description>Implantation of an uncovered metal duodenal prosthesis for symptomatic tumor stenosis</description>
    <arm_group_label>symptomatic non-covered duodenal prosthesis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Any symptomatic duodenal stenosis with symptomatic duodenal duodenal prosthesis between
        2010 and 2017.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any symptomatic duodenal stenosis with symptomatic duodenal duodenal prosthesis
             between 2010 and 2017.

        Exclusion Criteria:

          -  Benign stenosis or covered metallic duodenal prosthesis (usually indicated for benign
             disease)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabrice CAILLOL</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Paoli-Calmettes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fabrice CAILLOL</last_name>
    <phone>0491223531</phone>
    <email>CAILLOLF@ipc.unicancer.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean-Philippe RATONE</last_name>
    <phone>0491227727</phone>
    <email>RATONEJ@ipc.unicancer.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut Paoli Calmettes</name>
      <address>
        <city>Marseille</city>
        <state>Bouches Du Rhone</state>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique GENRE, MD</last_name>
      <phone>33 4 91 22 37 78</phone>
      <email>drci.up@ipc.unicancer.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Fiori E, Lamazza A, Volpino P, Burza A, Paparelli C, Cavallaro G, Schillaci A, Cangemi V. Palliative management of malignant antro-pyloric strictures. Gastroenterostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res. 2004 Jan-Feb;24(1):269-71.</citation>
    <PMID>15015607</PMID>
  </reference>
  <reference>
    <citation>Johnsson E, Thune A, Liedman B. Palliation of malignant gastroduodenal obstruction with open surgical bypass or endoscopic stenting: clinical outcome and health economic evaluation. World J Surg. 2004 Aug;28(8):812-7. Epub 2004 Aug 3.</citation>
    <PMID>15457364</PMID>
  </reference>
  <reference>
    <citation>Jeurnink SM, Steyerberg EW, Hof Gv, van Eijck CH, Kuipers EJ, Siersema PD. Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: a comparison in 95 patients. J Surg Oncol. 2007 Oct 1;96(5):389-96.</citation>
    <PMID>17474082</PMID>
  </reference>
  <reference>
    <citation>ASGE guidelines enteral stents</citation>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2018</study_first_submitted>
  <study_first_submitted_qc>March 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2018</study_first_posted>
  <last_update_submitted>March 12, 2018</last_update_submitted>
  <last_update_submitted_qc>March 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>duodenal stenosis</keyword>
  <keyword>pyloric stenosis</keyword>
  <keyword>digestive neoplasias</keyword>
  <keyword>non-digestive neoplasias</keyword>
  <keyword>duodenal prosthesis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

